Table 3.

Reported structures for successful encapsulation of remdesivir.

Type of Carriers	Size nm	ζ-Potential mV	Encapsulation Efficiency EE, %	Loaded Amount µg/ml	References
Aerosolized nanoliposomal carrier	71.46 ± 1.35	−32.00 ± 2.00	99.79	2.5	[55]
Lipid nanocarriers	43.00 ± 0.60	−6.84 ± 0.59	99.94	499.8	[56]
Liposomes in aerosol	120	−7.00	62.41–83.93 depends on the drug/lipid ratio	N/xn	[22]
hyperbranched dendritic nanocarriers	185.0 ± 30.5	−7.00	14.10		[57]
Dendrimer-drug conjugates	1704–7172	1.14–23.70	37.97–48.43 depends on the conditions	339.0	[58]